Resources

7 Resources for

valuehuntr

  • Subscribe to this listing via:
  • RSS
  • Email

BNET Resources

GE: Worst Case Scenario Ain't So Bad
ValueHuntr submits: A critical misconception behind [[GE]]’s latest stock plunge is that the industrial giant faces the same financial woes as Citigroup C, Bank of America BAC, and other major banks. Though the similarities are many, there are some startling differences. A common misconception...
Tags: Financial, ValueHuntr, General Electric Co.
External links 2009-03-17
What's Really Wrong with Wall Street
ValueHuntr submits: A common belief in Wall Street is that risk avoidance is incompatible with investment success. This view holds that high return is attainable only by incurring high risk and that investment success is...
Tags: US Market, ValueHuntr
External links 2009-03-22
Trident Microsystems: Net-Cash with a Catalyst
ValueHuntr submits: Trident Microsystems TRID is a company whose stock is trading substantially below its net-cash value. According to its latest SEC filing the company held nearly $212M in cash with $56M in total liabilities, for a net-cash value of $156M as of December 31, 2008. However, TRID’s market...
Tags: Chip, ValueHuntr, Trident Microsystems
External links 2009-04-01
Facet Biotech: Value Investing with a Catalyst
ValueHuntr submits: We are adding Facet Biotech Corporation to our ValueHuntr Portfolio. FACT is a company with a market cap of $239M ($9.72/share) with $295M ($12.00/share) of net-cash as of December 31, 2008. On December 18, 2008, Facet Biotech completed its spin-off from PDL BioPharma, Inc. PDL. PDL capitalized Facet...
Tags: Biotech, ValueHuntr
External links 2009-04-15
Vanda Pharma Surges on FDA Approval
ValueHuntr submits: Shares of Vanda Pharmaceuticals Inc. VNDA skyrocketed today after the company said the FDA approved its schizophrenia drug Fanapt. Vanda plans to begin shipping the drug to pharmacies later this year. The news sent Vanda shares surging nearly tenfold to $10.00 from $1.08. We purchased the stock at...
Tags: Biotech, Healthcare, ValueHuntr, Vanda Pharmaceuticals Inc.
External links 2009-05-07
Soapstone Networks Board Approves Liquidation
ValueHuntr submits: Soapstone Networks SOAP announced Monday that its Board of Directors has unanimously approved a plan of dissolution and liquidation of the Company. We added SOAP to the Valuehuntr Portfolio on March 9, 2009, after the company announced it was seeking strategic alternatives to enhance shareholder value....
Tags: Software, ValueHuntr
External links 2009-06-17
Life Sciences Research to Be Acquired in Going Private Transaction
ValueHuntr submits: Life Sciences Research, Inc. LSR announced Thursday that it has entered into a definitive merger agreement to be acquired by Lion Holdings, Inc., an entity controlled by LSR’s Chairman and Chief Executive Officer, Andrew Baker, for $8.50 per share in cash. Mr. Baker currently beneficially owns approximately 17.5%...
Tags: Biotech, ValueHuntr, Life Sciences Research Inc.
External links 2009-07-10
  • << Previous
  • page 1 of 1
  • Next >>
advertisement

Refining Tags

Biotech (3 results)
advertisement